PIK3CA and breast carcinoma: We and others identified a requirement for PI3K in the estrogen-independent growth of long-term estrogen-deprived (LTED) ER+ breast cancer cells, which mirror clinical resistance to AIs (Sabnis et al., 2007; Crowder et al., 2009; Miller et al., 2010).